Updated efficacy results from the JAVELIN Renal 101 trial: first-line avelumab plus axitinib versus sunitinib in patients with advanced renal cell carcinoma
Choueiri, T.K., Motzer, R.J., Rini, B.I., Haanen, J., Campbell, M.T., Venugopal, B., Kollmannsberger, C., Gravis-Mescam, G., Uemura, M., Lee, J.L., Grimm, M.-O., Gurney, H., Schmidinger, M., Larkin, J., Atkins, M.B., Pal, S.K., Wang, J., Mariani, M., Krishnaswami, S., Cislo, P., Chudnovsky, A., Fowst, C., Huang, B., di Pietro, A., Albiges, L.
Published in Annals of oncology (01.08.2020)
Published in Annals of oncology (01.08.2020)
Get full text
Journal Article
Characterisation and management of dermatologic adverse events to agents targeting the PD-1 receptor
Belum, V.R, Benhuri, B, Postow, M.A, Hellmann, M.D, Lesokhin, A.M, Segal, N.H, Motzer, R.J, Wu, S, Busam, K.J, Wolchok, J.D, Lacouture, M.E
Published in European journal of cancer (1990) (01.06.2016)
Published in European journal of cancer (1990) (01.06.2016)
Get full text
Journal Article
Outcomes of patients with metastatic clear-cell renal cell carcinoma treated with second-line VEGFR-TKI after first-line immune checkpoint inhibitors
Shah, A.Y., Kotecha, R.R., Lemke, E.A., Chandramohan, A., Chaim, J.L., Msaouel, P., Xiao, L., Gao, J., Campbell, M.T., Zurita, A.J., Wang, J., Corn, P.G., Jonasch, E., Motzer, R.J., Sharma, P., Voss, M.H., Tannir, N.M.
Published in European journal of cancer (1990) (01.06.2019)
Published in European journal of cancer (1990) (01.06.2019)
Get full text
Journal Article
Prognostic factors for survival in 1059 patients treated with sunitinib for metastatic renal cell carcinoma
Motzer, R J, Escudier, B, Bukowski, R, Rini, B I, Hutson, T E, Barrios, C H, Lin, X, Fly, K, Matczak, E, Gore, M E
Published in British journal of cancer (25.06.2013)
Published in British journal of cancer (25.06.2013)
Get full text
Journal Article
Incidence and management of mTOR inhibitor-associated pneumonitis in patients with metastatic renal cell carcinoma
Albiges, L., Chamming's, F., Duclos, B., Stern, M., Motzer, R.J., Ravaud, A., Camus, P.
Published in Annals of oncology (01.08.2012)
Published in Annals of oncology (01.08.2012)
Get full text
Journal Article
Immune‐related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
Zarbo, A., Belum, V.R., Sibaud, V., Oudard, S., Postow, M.A., Hsieh, J.J., Motzer, R.J., Busam, K.J., Lacouture, M.E.
Published in British journal of dermatology (1951) (01.06.2017)
Published in British journal of dermatology (1951) (01.06.2017)
Get full text
Journal Article
Axitinib versus sorafenib in advanced renal cell carcinoma: subanalyses by prior therapy from a randomised phase III trial
Escudier, B, Michaelson, M D, Motzer, R J, Hutson, T E, Clark, J I, Lim, H Y, Porfiri, E, Zalewski, P, Kannourakis, G, Staehler, M, Tarazi, J, Rosbrook, B, Cisar, L, Hariharan, S, Kim, S, Rini, B I
Published in British journal of cancer (10.06.2014)
Published in British journal of cancer (10.06.2014)
Get full text
Journal Article
Prognostic factors for progression-free and overall survival with sunitinib targeted therapy and with cytokine as first-line therapy in patients with metastatic renal cell carcinoma
Patil, S., Figlin, R.A., Hutson, T.E., Michaelson, M.D., Négrier, S., Kim, S.T., Huang, X., Motzer, R.J.
Published in Annals of oncology (01.02.2011)
Published in Annals of oncology (01.02.2011)
Get full text
Journal Article
Treatment outcome with mTOR inhibitors for metastatic renal cell carcinoma with nonclear and sarcomatoid histologies
Voss, M.H., Bastos, D.A., Karlo, C.A., Ajeti, A., Hakimi, A.A., Feldman, D.R., Hsieh, J.J., Molina, A.M., Patil, S., Motzer, R.J.
Published in Annals of oncology (01.03.2014)
Published in Annals of oncology (01.03.2014)
Get full text
Journal Article
Everolimus in metastatic renal cell carcinoma: Subgroup analysis of patients with 1 or 2 previous vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapies enrolled in the phase III RECORD-1 study
Calvo, E, Escudier, B, Motzer, R.J, Oudard, S, Hutson, T.E, Porta, C, Bracarda, S, Grünwald, V, Thompson, J.A, Ravaud, A, Kim, D, Panneerselvam, A, Anak, O, Figlin, R.A
Published in European journal of cancer (1990) (01.02.2012)
Published in European journal of cancer (1990) (01.02.2012)
Get full text
Journal Article
Meta-analysis of stomatitis in clinical studies of everolimus: incidence and relationship with efficacy
Rugo, H.S., Hortobagyi, G.N., Yao, J., Pavel, M., Ravaud, A., Franz, D., Ringeisen, F., Gallo, J., Rouyrre, N., Anak, O., Motzer, R.
Published in Annals of oncology (01.03.2016)
Published in Annals of oncology (01.03.2016)
Get full text
Journal Article
Efficacy and safety of sunitinib in elderly patients with metastatic renal cell carcinoma
Hutson, T E, Bukowski, R M, Rini, B I, Gore, M E, Larkin, J M, Figlin, R A, Barrios, C H, Escudier, B, Lin, X, Fly, K, Martell, B, Matczak, E, Motzer, R J
Published in British journal of cancer (04.03.2014)
Published in British journal of cancer (04.03.2014)
Get full text
Journal Article
Patient-reported outcomes for axitinib vs sorafenib in metastatic renal cell carcinoma: phase III (AXIS) trial
Cella, D, Escudier, B, Rini, B, Chen, C, Bhattacharyya, H, Tarazi, J, Rosbrook, B, Kim, S, Motzer, R
Published in British journal of cancer (30.04.2013)
Published in British journal of cancer (30.04.2013)
Get full text
Journal Article
Safety and clinical activity of vascular endothelial growth factor receptor (VEGFR)–tyrosine kinase inhibitors after programmed cell death 1 inhibitor treatment in patients with metastatic clear cell renal cell carcinoma
Nadal, R., Amin, A., Geynisman, D.M., Voss, M.H., Weinstock, M., Doyle, J., Zhang, Z., Viudez, A., Plimack, E.R., McDermott, D.F., Motzer, R., Rini, B., Hammers, H.J.
Published in Annals of oncology (01.07.2016)
Published in Annals of oncology (01.07.2016)
Get full text
Journal Article
A randomized phase II trial of CRLX101 in combination with bevacizumab versus standard of care in patients with advanced renal cell carcinoma
Voss, M.H., Hussain, A., Vogelzang, N., Lee, J.L., Keam, B., Rha, S.Y., Vaishampayan, U., Harris, W.B., Richey, S., Randall, J.M., Shaffer, D., Cohn, A., Crowell, T., Li, J., Senderowicz, A., Stone, E., Figlin, R., Motzer, R.J., Haas, N.B., Hutson, T.
Published in Annals of oncology (01.11.2017)
Published in Annals of oncology (01.11.2017)
Get full text
Journal Article
Neutrophil chemokines secreted by tumor cells mount a lung antimetastatic response during renal cell carcinoma progression
López-Lago, M A, Posner, S, Thodima, V J, Molina, A M, Motzer, R J, Chaganti, R S K
Published in Oncogene (04.04.2013)
Published in Oncogene (04.04.2013)
Get full text
Journal Article
Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC
Knox, J.J., Barrios, C.H., Kim, T.M., Cosgriff, T., Srimuninnimit, V., Pittman, K., Sabbatini, R., Rha, S.Y., Flaig, T.W., Page, R.D., Beck, J.T., Cheung, F., Yadav, S., Patel, P., Geoffrois, L., Niolat, J., Berkowitz, N., Marker, M., Chen, D., Motzer, R.J.
Published in Annals of oncology (01.06.2017)
Published in Annals of oncology (01.06.2017)
Get full text
Journal Article